Dunn Medicine
Hangzhou
About Dunn Medicine
Dunn Medicine is a clinical precision medication guidance service provider. The company mainly focuses on rational drug use. To this end, it focuses on building molecular platforms and mass spectrometry platforms. Its molecular platforms include fluorescence quantitative PCR instruments, illumina second-generation sequencers, and ABI first-generation sequencers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $15.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2024)
- Website: dunen.netindex.html
- Phone: 0571-82357107
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/dunn-medicine-105529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.